Lv2
150 积分 2023-02-18 加入
Effectiveness and safety of telitacicept in patients with systemic lupus erythematosus: a single-center, retrospective, real-world study
13天前
已完结
Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
7个月前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
7个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
8个月前
已完结
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
8个月前
已关闭
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
8个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
8个月前
已完结
Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
8个月前
已关闭
The pathogenesis and treatment in antineutrophil cytoplasmic antibody associate
9个月前
已完结
皖公网安备34019202002308
